Amalgamated Bank Lowers Holdings in STERIS plc (NYSE:STE)

Amalgamated Bank decreased its holdings in STERIS plc (NYSE:STE) by 1.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 19,092 shares of the medical equipment provider’s stock after selling 283 shares during the quarter. Amalgamated Bank’s holdings in STERIS were worth $3,925,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in STE. Ashton Thomas Securities LLC bought a new position in STERIS in the 3rd quarter worth approximately $25,000. Human Investing LLC purchased a new position in shares of STERIS in the fourth quarter worth $31,000. Central Pacific Bank Trust Division boosted its position in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares during the last quarter. Manchester Capital Management LLC boosted its position in shares of STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 137 shares during the last quarter. Finally, Quarry LP purchased a new position in STERIS during the third quarter valued at $67,000. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

STE has been the topic of several research analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Stephens reiterated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler increased their price target on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Stock Performance

Shares of NYSE:STE opened at $219.23 on Friday. The firm has a fifty day simple moving average of $214.76 and a two-hundred day simple moving average of $223.11. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $21.54 billion, a P/E ratio of 46.54 and a beta of 0.84. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be issued a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.04%. STERIS’s payout ratio is presently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.